Net sales grew 1% year-over-year in Q2 2026, with stable gross margins and EBITA, but EBIT and net profit were heavily impacted by a MSEK 600 non-cash goodwill impairment in Sustainable Care. Strategic divestments and investments continued, and leverage increased to 2.8x.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.